Aminothiazole derivatives and their uses as antibacterial agents

Details for Australian Patent Application No. 2007255025 (hide)

Owner Novartis AG

Inventors Lamarche, Matthew J.; Bushell, Simon; Patane, Michael A.; Whitehead, Lewis

Agent Davies Collison Cave

Pub. Number AU-B-2007255025

PCT Pub. Number WO2007/142986

Priority 60/809,693 31.05.06 US

Filing date 30 May 2007

Wipo publication date 13 December 2007

Acceptance publication date 14 July 2011

International Classifications

C07K 5/06 (2006.01) Peptides having up to four amino acids in a fully defined sequence

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

30 October 2008 PCT application entered the National Phase

  PCT publication WO2007/142986 Priority application(s): WO2007/142986

14 July 2011 Application Accepted

  Published as AU-B-2007255025

10 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007255038-Regulation of transforming growth factor-beta (TGF-beta) gene expression in living cells via the application of specific and selective electric and electromagnetic fields

2007255019-Handheld wagering game system and methods for conducting wagering games thereupon